VTLi Nurse Patient Results screen

Clinical Evidence:
Atellica® VTLi Patient-side Immunoassay Analyzer
Articles in Scientific Publications

Read articles

Point-of-care high-sensitivity cardiac troponin in suspected acute myocardial infarction assessed at baseline and 2 h
Authors: Cullen L., Apple F., et. al.
2024 Study Published in the European Heart Journal

New international multicenter study showcasing the impact of the Atellica® VTLi high-sensitivity troponin I (hs-cTnI) assay in the emergency assessment of patients with suspected acute myocardial infarction (AMI).

What percentage (range) of suspected ACS patients could be assessed “low risk” based on VTLi hs-cTnI test results per the recent publication in European Heart Journal by Cullen L. et al?


0%

Determination of a wholeblood single-test low-risk threshold for a point-of-care high-sensitivity troponin assay
Authors: Pickering J., Than M., et.al.
2024 Study Published in the Emergency Medicine Journal

To enhance care delivery in emergency departments (EDs) through faster risk-stratification methods, this study showcases initial findings from the ICare-FASTER interventional clinical trial.  Focusing on point-of-care technology within an Accelerated Diagnostic algorithm (0-2 h), it discusses the clinical utilization of this algorithm conducted at Christchurch Hospital in New Zealand and highlights its impact on reducinTo enhance care delivery in emergency departments (EDs) through faster risk-stratification methods, this study showcases initial findings from the ICare-FASTER interventional clinical trial.  Focusing on point-of-care technology within an Accelerated Diagnostic algorithm (0-2 h), it discusses the clinical utilization of this algorithm conducted at Christchurch Hospital in New Zealand and highlights its impact on reducing the overall length of stay for patients.

Which rapid algorithm/s with high-sensitive troponin assays do ESC guidelines recommend to rule-in and rule-out NSTEMI?